Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy
- 1 April 2002
- journal article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 17 (4), 302-304
- https://doi.org/10.1007/s00467-002-0829-y
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathyAmerican Journal of Kidney Diseases, 2001
- Pathophysiology and treatment of IgA nephropathy in children.Pediatric Nephrology, 2001
- Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathyAmerican Journal of Kidney Diseases, 1999
- A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.1999
- Blood Pressure Control, Proteinuria, and the Progression of Renal DiseaseAnnals of Internal Medicine, 1995
- Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up.1995
- Long-term Benefits of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Severe Immunoglobulin A Nephropathy: A Comparison to Patients Receiving Treatment With Other Antihypertensive Agents and to Patients Receiving No TherapyAmerican Journal of Kidney Diseases, 1994
- Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.JCI Insight, 1993
- Levels of angiotensin and molecular biology of the tissue renin angiotensin systemsRegulatory Peptides, 1993
- Plasma angiotensins and blood pressure during converting enzyme inhibition.Hypertension, 1987